Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by PolarityTE, Inc.

PolarityTE to Attend H.C. Wainwright 23rd Annual Global Investment Conference and 2021 Cantor Virtual Global Healthcare Conference
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Appoints Richard Hague as Chief Executive Officer and Elects David Seaburg to Board of Directors and Chair of Strategic Review Committee
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Reports Second Quarter Financial Results and Provides Business Update
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE to Report Second Quarter Financial Results on August 12, 2021
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Issues Statement About Potential Ticker Symbol Confusion
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Receives Notice of Allowance for Chinese Patent
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Reports First Quarter Results and Provides Business Update
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
PolarityTE to Report First Quarter Financial Results on May 13, 2021
From PolarityTE, Inc.
Via Business Wire
Tickers PTE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.